March 8, 2021

3.4 Percent of U.S. Workers Are Current E-Cigarette Users

MONDAY, March 8, 2021 (HealthDay News) — About 3.4 percent of U.S. workers are current electronic cigarette users, and about half also currently use combustible tobacco products, according to research published in the March 5 issue of the U.S. Centers for Disease Control and Prevention Morbidity and Mortality Weekly Report. Girija Syamlal, M.B.B.S., from the...

Tobacco Exposure Tied to Hypertension in Children

MONDAY, March 8, 2021 (HealthDay News) — Tobacco exposure is associated with elevated blood pressure in U.S. children and adolescents, according to a study published online Feb. 23 in JAMA Network Open. Rebecca V. Levy, B.M., B.Ch., from Montefiore Medical Center in New York City, and colleagues used data from the 2007 to 2016 U.S....

Erythrocytosis ID'd in 11 Percent of Trans Men Using Testosterone

MONDAY, March 8, 2021 (HealthDay News) — Eleven percent of trans men using testosterone have erythrocytosis (more than two measurements of hematocrit >0.50 L/L), according to a study published online Feb. 18 in the Journal of Clinical Endocrinology & Metabolism. Milou Cecilia Madsen, M.D., from Vrije Universiteit Amsterdam, and colleagues examined prevalence and determinants in...

Erythrocytosis ID'd in 11 Percent of Trans Men Using Testosterone

MONDAY, March 8, 2021 (HealthDay News) — Eleven percent of trans men using testosterone have erythrocytosis (more than two measurements of hematocrit >0.50 L/L), according to a study published online Feb. 18 in the Journal of Clinical Endocrinology & Metabolism. Milou Cecilia Madsen, M.D., from Vrije Universiteit Amsterdam, and colleagues examined prevalence and determinants in...

Erythrocytosis ID'd in 11 Percent of Trans Men Using Testosterone

MONDAY, March 8, 2021 (HealthDay News) — Eleven percent of trans men using testosterone have erythrocytosis (more than two measurements of hematocrit >0.50 L/L), according to a study published online Feb. 18 in the Journal of Clinical Endocrinology & Metabolism. Milou Cecilia Madsen, M.D., from Vrije Universiteit Amsterdam, and colleagues examined prevalence and determinants in...

Erythrocytosis ID'd in 11 Percent of Trans Men Using Testosterone

MONDAY, March 8, 2021 (HealthDay News) — Eleven percent of trans men using testosterone have erythrocytosis (more than two measurements of hematocrit >0.50 L/L), according to a study published online Feb. 18 in the Journal of Clinical Endocrinology & Metabolism. Milou Cecilia Madsen, M.D., from Vrije Universiteit Amsterdam, and colleagues examined prevalence and determinants in...

Erythrocytosis ID'd in 11 Percent of Trans Men Using Testosterone

MONDAY, March 8, 2021 (HealthDay News) — Eleven percent of trans men using testosterone have erythrocytosis (more than two measurements of hematocrit >0.50 L/L), according to a study published online Feb. 18 in the Journal of Clinical Endocrinology & Metabolism. Milou Cecilia Madsen, M.D., from Vrije Universiteit Amsterdam, and colleagues examined prevalence and determinants in...

Erythrocytosis ID'd in 11 Percent of Trans Men Using Testosterone

MONDAY, March 8, 2021 (HealthDay News) — Eleven percent of trans men using testosterone have erythrocytosis (more than two measurements of hematocrit >0.50 L/L), according to a study published online Feb. 18 in the Journal of Clinical Endocrinology & Metabolism. Milou Cecilia Madsen, M.D., from Vrije Universiteit Amsterdam, and colleagues examined prevalence and determinants in...

Erythrocytosis ID'd in 11 Percent of Trans Men Using Testosterone

MONDAY, March 8, 2021 (HealthDay News) — Eleven percent of trans men using testosterone have erythrocytosis (more than two measurements of hematocrit >0.50 L/L), according to a study published online Feb. 18 in the Journal of Clinical Endocrinology & Metabolism. Milou Cecilia Madsen, M.D., from Vrije Universiteit Amsterdam, and colleagues examined prevalence and determinants in...
<<
  • 1
  • 2
>>

Stay informed on the latest health disparities research, cultural sensitivity education, and how you can help improve patient outcomes.
This field is for validation purposes and should be left unchanged.